Skip to main content
. 2022 Aug 3;2022(8):CD015270. doi: 10.1002/14651858.CD015270

NCT05022472 (2VIDA!).

Study name Project 2VIDA! COVID‐19 Vaccine Intervention Delivery for Adults in southern California (2VIDA!)
Starting date 26 August 2021
Contact information Argentina E Servin, MD,MPH; 6195767211; arservin@ucsd.edu
Methods 
  • Study design: randomised controlled trial

  • Type of publication: trial registration

  • Setting: Latino and African American (AA) communities in Southern California, NR

  • Country: USA

  • Language: English and Spanish

Intervention Multidimensional community intervention
  • Behavioral: COVID‐19 Individual Awareness and Education.

  • Behavioral: COVID‐19 Community Outreach & Health Promotion.

  • Behavioral: COVID‐19 Individual Health Education & Linkages to Medical and Supportive Services.

  • Biological: Pop‐up community vaccination sites

  • No intervention: standard care (Standard for vaccine delivery)

Population 
  • Population: general population

  • Inclusion criteria: 

    • age 18 years or older

    • identify as Latinx and/or AA

    • biologically male or female

    • be a resident of one of the six communities selected for this study (National City, Lincoln Park, Logan Heights, Valencia Park, Chula Vista or San Ysidro)

    • literate in English or Spanish

    • no known history of severe allergic reactions to any components of the vaccine

    • no history of immune disease

    • not pregnant

    • no plans to move from the area in the following 30 days

    • able to provide voluntary informed consent

    • able to provide complete contact information for themselves and two additional contact individuals (for follow‐up 2nd vaccine shot)

  • Exclusion criteria: 

    • under 18 years old

    • pregnant women

    • adults unable to consent

Outcomes Primary outcomes
  • COVID‐19 vaccine acceptance

  • Vaccine hesitancy


Secondary outcomes
  • Change in health literacy 

  • Change in COVID‐19 risk perception

  • Change in preparedness and perceived self‐efficacy

  • Change in prevention (own behaviours) 

  • Testing and tracing

  • Access to health care and utilisation

  • Health history


Other outcomes
  • Affect 

  • Use of sources of information

  • Policies and interventions (perceptions) 

  • Trust in sources of information

  • Frequency of information

  • Perceptions of government responses to COVID‐19 pandemic

  • Trust in institutions (perceptions) 

  • Conspiracies (perceptions)

  • Resilience (perceptions) 

Estimated completion date and number of participants 31 January 2026, 1000 participants
Notes
  • COI: NR

  • Funding: Argentina Servin, MD, MPH